Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents

• US 6,495,676 B1
• Filed: 09/03/1999
• Issued: 12/17/2002
• Est. Priority Date: 04/13/1993
• Status: Expired due to Fees

• Current Assignee: Douglas Y. Thien
• Original Assignee: Naxcor
• Inventors: Albagli, David, Cheng, Peter C., Van Atta, Reuel B., Huan, Bingfang, Wood, Michael L., Thien, Douglas Y.
• Primary Examiner(s): Carr, Deborah D.
• Assistant Examiner(s): Crane, Lawrence E.
• Application Number:
  US09/390,124
• Time in Patent Office: 1,201 Days
• Field of Search: 435/6, 536/25.3, 536/25.31, 536/25.32
• US Class Current: 536/25.3
• CPC Class Codes: B01L 2300/1883 using thermal insulation
• CPC Class Codes: B01L 7/52 with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples amplification or hybridisation processes per se C12Q1/68; controlling sequential reactions for synthesis B01J19/0046
• CPC Class Codes: C07D 311/16 substituted in position 7
• CPC Class Codes: C07D 407/12 linked by a chain containing hetero atoms as chain links
• CPC Class Codes: C07F 9/65522 condensed with carbocyclic rings or carbocyclic ring systems
• CPC Class Codes: C07F 9/6561 containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C12Q 1/682 Signal amplification
• CPC Class Codes: C12Q 2523/101 Crosslinking agents, e.g. psoralen
• CPC Class Codes: C12Q 2525/101 incorporating non-naturally occurring nucleotides, e.g. inosine
• CPC Class Codes: C12Q 2537/119 Triple helix formation
• CPC Class Codes: C12Q 2565/107 Alteration in the property of hybridised versus free label oligonucleotides
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Methods and compositions are provided for detecting nucleic acid sequences. Probes comprising a crosslinking agent are combined with a sample which may comprise a target sequence which is complementary to the probe. Hybridization is allowed to occur between complementary sequences. The crosslinking agent is activated. Covalent bonds are formed between the probe and the target sequence if they are hybridized to one another. The crosslinked nucleic acids can then be detected to indicate the presence of the target sequence. Also provided are kits comprising reagents.

Claims

1. A method of detecting a target nucleic acid in a sample, said method comprising the steps of:

a) hybridizing a target nucleic acid to a crosslinkable probe, said crosslinkable probe comprising;

i) a polynucleotide having a sequence complementary to that of said target nucleic acid;

ii) a crosslinking moiety comprising a non-nucleosidic coumarin derivative incorporated into the backbone of said polynucleotide such that it replaces one or more nucleotides otherwise complementary to said target nucleic acid, wherein said coumain derivative is linked to a (poly)hydroxy hydrocarbon backbone moiety other than ribose or deoxyribose; and

iii) optionally at least one label;

b) activating said crosslinking moiety, whereby a covalent crosslink occurs between said probe and said target nucleic acid; and

c) detecting the presence of a crosslinked nucleic acid pair as indicative of the presence of said target sequence in said sample.

2. The method of claim 1 wherein the target nucleic acid is from a microorganism selected from the group consisting of Chlamydia, Neisseria, Mycobacterium, Mycoplasma, Legionella and Listeria monocytogenes.

3. The method of claim 1 wherein the target nucleic acid is from a microorganism selected from the group consisting of Haemophilus ducreyi, Treponema pallidum, Helicobacter pylori, Pneumocystis carinii, Borrelia burgdorferi, Salmonella, HIV I and II, HTLV-II, Hepatitis A, B, C, and D, Cytomegalovirus, human Papillomavirus, Respiratory syncytial virus, Epstein-Barr virus, Dengue virus, Eastern and Western Encephalitus viruses, Ebola virus, and Lassa virus.

4. The method of claim 1, wherein the target nucleic acid is selected from the group consisting of the TEM-1 gene (β

-lactamase) in Enterobacteriaceae;

the TEM-1 gene in penicillinase producing N. gonorrhoeae (PPNG);

the gene conferring aminoglycoside antibiotic resistance;

the gene conferring erythromycin resistance;

the gene conferring rifampin resistance and the gene conferring vancomycin resistance.

5. The method of claim 1 wherein the target nucleic acid is selected from the group consisting of fetal DNA, genes indicating sex of a fetus, the factor V gene, the factor V gene having the Leiden mutation, the hemochromatosis gene, the factor II gene and a gene known to be unique to human chromosome 21.

6. The method of claim 1 wherein said crosslinkable probe further comprises at least one label.

7. The method of claim 1, wherein said label is selected from the group consisting of an antibody ligand, a lectin-binding sugar and biotin.

8. The method of claim 1, wherein said label is selected from the group consisting of a chemiluminescer, a radiolabel and a fluorophore.

9. The method of claim 6 wherein said label is an antigen.

10. The method of claim 1 further comprising the step of:

d) isolating said crosslinked nucleic acid pair.

11. The method of claim 1 wherein said target nucleic acid in a sample is genomic DNA.

12. The method of claim 1 wherein said target nucleic acid in a sample is genomic DNA derived from whole blood.

13. A method according to claim 1 wherein multiple samples are assayed for one or more target nucleic acids in an automated system.

14. A kit including components for detecting a target nucleic acid in a sample, said kit comprising:

a) a crosslinkable probe comprising;

i) a polynucleotide having a sequence complementary to that of said target and capable of hybridizing with said target nucleic acid;

ii) a crosslinking moiety comprising a non-nucleosidic coumarin derivative incorporated into the backbone of said polynucleotide such that it replaces one or more nucleotides otherwise complementary to said target nucleic acid, wherein said coumarin derivative is linked to a (poly)hydroxy hydrocarbon backbone moiety other than ribose or deoxyribose; and

iii) optionally at least one label; and

b) a control.

15. A kit according to claim 14 wherein said crosslinkable probe is a first crosslinkable probe, and wherein said kit further comprises at least one second crosslinkable probe, said second crosslinkable probe comprising:

i) a polynucleotide having a sequence complementary to that of said target nucleic acid;

ii) a crosslinking moiety comprising a non-nucleosidic coumarin derivative incorporated into the backbone of said polynucleotide such that it replaces one or more nucleotides otherwise complementary to said target nucleic acid, wherein said coumarin derivative is linked to a (poly)hydroxy hydrocarbon backbone moiety other than ribose or deoxyribose; and

iii) optionally at least one label.

16. A kit according to claim 15 wherein each of said first and second crosslinkable probes are characterized by having a label, wherein one of said labels is a member of a specific binding pair, and one of said labels provides a detectable signal.

17. The kit of claim 14 wherein said control is a purified plasmid containing the nucleic acid sequence to be detected.

18. The kit of claim 14 wherein said control is an amplicon of the region of the target nucleic acid to be detected.

19. A method of detecting a target nucleic acid in a sample, said method comprising the steps of:

a) hybridizing a target nucleic acid to at least a first and a second crosslinkable probe, said crosslinkable probes comprising;

i) a polynucleotide having a sequence complementary to that of said target nucleic acid;

ii) a crosslinking moiety comprising a non-nucleosidic coumarin derivative incorporated into the backbone of said polynucleotide such that it replaces one or more nucleotides otherwise complementary to said target nucleic acid, wherein said coumarin derivative is linked to a (poly)hydroxy hydrocarbon backbone moiety other than ribose or deoxyribose; and

iii) optionally at least one label;

b) activating said crosslinking moiety, whereby a covalent crosslink occurs between said first and second crosslinkable probes and said target nucleic acid; and

c) detecting the presence of a crosslinked nucleic acid pair as indicative of the presence of said target sequence in said sample.

20. The method of claim 19 wherein at least one of said first or second crosslinkable probes is characterized by having at least one label.

21. The method of claim 20, wherein said label is selected from the group consisting of an antibody ligand, a lectin-binding sugar and biotin.

22. The method of claim 20, wherein said label is selected from the group consisting of a chemiluminescer, a radiolabel and a fluorophore.

23. The method of claim 20, wherein said label is an antigen.

24. The method of claim 19, wherein each of said first and second crosslinkable probes are characterized by having a label, wherein one of said labels is a member of a specific binding pair, and one of said labels provides a detectable signal.